| HOME | HELP | E-MAIL ALERTS | SEARCH |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
PEDIATRICS Vol. 99 No. 6 June 1997, pp. 904-908
 |
ABSTRACT |
|---|
Top
Abstract
Background
Conclusion
References
|
|---|
This revision of a previous statement by the American Academy of Pediatrics provides current information on anabolic steroid use by young athletes. It provides the information needed to enable pediatricians to discuss the benefits and risks of anabolic steroids in a well-informed, nonjudgmental fashion.
The use of a variety of substances has long accompanied efforts to
enhance athletic performance.1 Such use is not limited to professional and Olympic athletes. Studies focusing on anabolic steroids have shown a continuing and significant increase of use among
adolescent athletes and nonathletes alike (Table
1).2-5 In response to the alarming high
rate of use of anabolic steroids and the attendant medical risks,
policy statements were issued by the American Academy of Pediatrics in
1989 and the American College of Sports Medicine in 1977 and
1984.6-8 These statements condemn the use of anabolic
steroids but acknowledge that they may enhance strength. It has become
evident that prohibitions against anabolic steroid use and claims that
steroids lack efficacy or produce harm have been insufficient to
curtail their use.9-11
TABLE 1
DEFINITION OF THE PROBLEM
Prevalence of Androgenic Anabolic Steroid Abuse*
The American Academy of Pediatrics continues to condemn the use of anabolic steroids for body building or enhancement of sports performance. However, many users, their parents, and their coaches feel that anabolic steroids are useful and even necessary for optimal performance. The Academy's strong opposition to anabolic steroid use may be offset by societies' high rewards for success in sports and a "win at all costs" attitude. Adolescents must interpret mixed messages about the appropriateness of anabolic steroid use as well as ambiguous messages about the benefits and risks of using anabolic steroids. There is a clear need for input that is objective, rational, nonbiased, and readily available to the adolescent. If pediatricians and other pediatric health care advocates are to serve as a much needed "voice of reason," they must be familiar with current information on the risks and benefits of anabolic steroids, use patterns, and the incentives and disincentives for use.
| |
BACKGROUND |
|---|
|
Top
Abstract
Background
Conclusion
References
|
|---|
Nonmedical use of anabolic steroids was initially reported in weight lifters and other "strength" athletes in the 1950s.13 The purported benefit to these athletes was a gain in strength and muscle size beyond that which could be achieved with rigorous training and diet alone. The strength gains and performance-enhancing benefits from anabolic steroids were challenged and often discounted by early medical studies. In 1984, Haupt and Rovere14 thoroughly reviewed published studies on the efficacy of anabolic steroids. Gains in muscle strength and size do occur, and have been most consistent among subjects using anabolic steroids in conjunction with an adequate dietary nitrogen supply and an adequate strength-training program. The benefit of increased muscle size and strength on sports performance appears to vary with the physical demands of the sport. The benefit is potentially more significant in strength-dependent sports such as weight lifting, shot put throwing, and football (linemen). Increased muscle size and bulk have fewer potential benefits for participation in sports that require speed, agility, flexibility, and/or endurance.
Administration and Mechanisms of Action
Anabolic steroids may be administered orally or by intramuscular injection.15 Some of the common orally administered anabolic steroids include oxymetholone (Anadrol), oxandrolone (Anavar), methandrostenolone (Dianabol), and stanozolol (Winstrol). Some of the injectable steroids include nandrolone decanoate (Deca-Durabolin), nandrolone phenpropionate (Durabolin), testosterone cypionate (Depo-Testosterone), and boldenone undecylenate (Equipoise).
Individuals using anabolic steroids typically use a combination of oral and injectable drugs during 6- to 12-week cycles. The injectable forms are favored by users because they are less hepatotoxic than oral preparations. However, the oral preparations tend to be cleared more rapidly from the system and may be preferred when drug testing is anticipated.
The simultaneous use of multiple steroid preparations is called "stacking," and the pattern of increasing a dose through a cycle is referred to as "pyramiding." Pyramiding may lead to doses of 10 to 40 times greater than those used for medical indications. Stacking and pyramiding are intended to maximize steroid receptor binding and minimize toxic side effects. The fact that these benefits have not been substantiated scientifically has not appreciably influenced dosing patterns.
Anabolic steroids are believed to exert their effects by binding to androgen receptors at the cellular level, stimulating production of RNA, and ultimately increasing protein synthesis. The various clinical effects are determined by the type and concentrations of androgen receptors and enzymes controlling steroid metabolism in a given organ. The structure of androgen receptors appears to be identical in muscle and other organs.
Anabolic steroids have been shown to have an anticatabolic effect by improving utilization of protein and by inhibiting the catabolic effect of glucocorticoids.14,16 In addition, anabolic steroids may lead to gains in strength by increasing the athlete's aggressiveness, producing euphoria, or decreasing the athlete's sense of fatigue during training. These psychological effects may allow a higher intensity and longer duration of training. A summary of the desired effects of anabolic steroids in sports competitors appears in Table 2.
|
Side Effects
Many excellent reviews on the adverse effects of anabolic steroids are available (Table 3).14-21 Because clinical trials are not feasible, much of the information on adverse reactions is anecdotal, or is assumed from known problems associated with therapeutic use of these agents.
|
Elevations in levels of liver enzymes (aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase) are common, whereas the more severe hepatic complications are rare. In men, steroid use depresses levels of luteinizing hormone and follicle-stimulating hormones, which leads to decreased endogenous testosterone production, decreased spermatogenesis, and testicular atrophy. Gynecomastia may result from the peripheral conversion of androgens to estradiol and estrone. The masculinizing effects of anabolic steroids in women include hirsutism, acne, deepening of the voice, clitoral hypertrophy, and male-pattern baldness. These androgenic effects may be irreversible.
Anabolic steroids may adversely affect the serum lipid profile, but their long-term effects on the development of coronary artery disease have not been determined. Thrombotic phenomena associated with anabolic steroid use include strokes, myocardial infarctions, and limb loss.22,23
Some individuals may experience mental status and behavioral changes with anabolic steroid use, including irritability, aggressiveness, euphoria, depression, mood swings, altered libido, and even psychosis.24 Anabolic steroid withdrawal and dependency disorders have also been reported.25 Acute anabolic steroid withdrawal may produce symptoms of central nonadrenergic hyperactivity including anxiety, irritability, insomnia, hot flashes, sweats, chills, anorexia, myalgia, nausea, vomiting, piloerection, tachycardia, and hypertension. Depression and anabolic steroid craving may also occur with withdrawal.25
Of particular concern is premature physeal closure in any child/adolescent, which results in a decrease in adult height.
Patterns of Anabolic Steroid Use
Surveys on the prevalence of anabolic steroid use in various populations continue to be published (Table 1).15 The prevalence of self-reported use of anabolic steroids in adolescents has ranged from 5% to 11% of males2-4 and up to 2.5% of females.5 Athletes in nonschool sports as well as nonathletes have been shown to represent a significant portion of the user population.12
Combined drug use patterns are seen when anabolic steroid users take additional nonsteroidal substances such as human growth hormone26 or clenbuterol27 for performance enhancement or anabolic effect. Durant et al28 showed that anabolic steroid use in adolescents was significantly associated with previous use of cocaine, injectable drugs, alcohol, marijuana, shared needles, and smokeless tobacco. An 18-year-old male who used injectable anabolic steroids has been reported to have acquired immunodeficiency virus infection from sharing needles and syringes.29
| |
SUMMARY OF EMERGING DATA |
|---|
New reports of previously unrecognized patterns of use, side effects, or complications of anabolic steroids continue to emerge. Perhaps the most compelling aspect of the "new literature" is what is not reported. To our knowledge, no study has identified an adolescent population without the temptation and risks of anabolic steroid use. Furthermore, no study has been published showing a decrease in the prevalence of anabolic steroid use over time (though a recent American Medical Association report suggests that this may be occurring) or in response to educational programs.
Educational programs directed toward potential users of anabolic steroids have been advocated with the hope that greater knowledge of medical risk would discourage use.6 Unfortunately, greater knowledge does not clearly change attitudes or behaviors.10 Educational programs that are biased toward presenting negative side effects (scare tactics) tend to widen the credibility gap between anabolic steroid users and health professionals.9 Even if the potential benefits of anabolic steroids are acknowledged, many health professionals are concerned that admitting to such benefits may inadvertently condone their use.
Drug-testing programs at the collegiate and Olympic level do not appear to deter anabolic steroid use in aspiring adolescent athletes. In fact, public reporting of drug use violations may paradoxically serve to promote the perceived performance-enhancing benefits of anabolic steroids.9 Drug testing for these agents at the high school or youth sport levels is impractical and unlikely to occur. Furthermore, sanctions against anabolic steroid users are not enforceable without direct proof of drug use.
| |
CONCLUSIONS |
|---|
|
Top
Abstract
Background
Conclusion
References
|
|---|
Pediatric practitioners cannot depend on community education programs or drug testing to curb the use of anabolic steroids in adolescents. Without evidence to show a significant and consistent decline in use or increasing safety of anabolic steroids, a passive approach to the problem is difficult to justify. The medical community is united in its belief that the use of anabolic steroids and other performance-enhancing substances is unacceptable, therefore, health care providers are obligated to provide sound guidance for those who seek advice.
Pediatricians have an opportunity to fulfill a positive role in the recognition and management of anabolic steroid abuse in adolescents. Recognition begins with an appreciation of the at-risk population. Potential anabolic steroid users have been and will continue to be involved in sports where strength and muscle mass are at a premium. Endurance athletes, female athletes, and nonathletes seeking to add strength, bulk, muscle definition, or to improve their self-image must also be considered to be at risk. It is appropriate for pediatricians to inquire about anabolic steroid use during routine health maintenance visits because of the general health risks and the general distribution of the population at risk.
Because recognition of the anabolic steroid user is unlikely to result from drug testing or disclosure by patients or by the supplier of the drug, physicians must recognize clinical signs that suggest use. Any of the adverse effects in Table 3 may occur, but the pediatrician is most likely to note changes such as otherwise improbable gains in lean body mass, gains in muscle bulk and definition, and behavioral changes such as increased aggressiveness and/or emotional lability. The adolescent anabolic steroid user may also show advanced stages of acne on the chest and back, gynecomastia, early male-pattern baldness, jaundice, and/or testicular atrophy. Blood pressure elevations are common, as are elevated levels of total cholesterol and depressed levels of high-density lipoprotein cholesterol.
If use of anabolic steroids or other performance-enhancing substances
is suspected, clinicians must respond in a manner that does not
alienate the patient. Responses that are confrontational, judgmental,
or in violation of doctor-patient confidentiality will quickly
eliminate any opportunity to influence the patient's decision making.
It is also important to understand the anabolic steroid user's
perspective
that the rewards for excellence in sports or a muscular
body outweigh the penalties and risks associated with anabolic steroid
use.30,33 A balanced, informed discussion about the
benefits and risks of anabolic steroids is preferable to scare tactics
or a one-sided discourse on the inconsistencies and inadequacies of the
available medical literature.
The credibility gap between anabolic steroid users and medical personnel can be narrowed by honest acknowledgment that anabolic steroids can have physical effects deemed desirable and even necessary by the user. It may be helpful to distinguish common, non-life-threatening side effects (acne, gynecomastia, balding) from the more rare and potentially fatal complications such as malignancies or thrombotic phenomena.
Anabolic steroid users and potential users should be aware that many of the adverse effects of anabolic steroids may be present without obvious warning signs. Examination of the patient for hypertension, cholesterol and lipid abnormalities, and/or hepatocellular damage, even if none of these are found, can impart a strong message that anabolic steroids can have serious side effects. Testing or laboratory determination for these side effects should include a disclaimer that testing does not condone use and that a negative test does not guarantee freedom from complications.
Medical issues related to anabolic steroid use are only part of the decision-making process. Some anabolic steroid users believe that, regardless of medical consequences, steroids are necessary to be competitive. Other athletes believe that steroid use precludes fair competition and that any success an athlete achieves while using steroids is tainted. Coaches are often influential in an athlete's decision-making process about whether to use anabolic steroids but may give ambiguous messages about what is necessary for success and what is fair in competition.
Part of drug-prevention counseling is providing a healthy alternative to drug use. Most athletes will find a way to meet their sports goals without using anabolic steroids. Athletes may need to be reminded that the health, fitness, and social benefits of sports participation can be readily met without use of performance-enhancing substances. For the athlete who is convinced that steroids are essential for success, it may be helpful to point out role models in the sports community whose success did not depend on the use of drugs.
Current clinical experience and scientific evidence support an approach to the anabolic steroid issue that minimizes preconceptions about the users, recognizes the potential benefits as well as risks of use, and maximizes informed, balanced, and open interaction with patients. There is ample need and justification for pediatric health care practitioners to be increasingly involved in the care of individuals who are using or considering use of these substances.
COMMITTEE ON SPORTS MEDICINE AND FITNESS, 1996 TO 1997
Steven J. Anderson, MD, Chair
Stephen P. Bolduc, MD
Elizabeth Coryllos, MD
Bernard Griesemer, MD
Larry McLain, MD
Thomas W. Rowland, MD
Suzanne M. Tanner, MD
LIAISON REPRESENTATIVES
Kathryn Keely, MD
Canadian Paediatric Society
Richard Malacrea, ATC
National Athletic Trainers Association
Judith C. Young, PhD
National Association for Sport and Physical
Education
AAP SECTION LIAISONS
Reginald L. Washington, MD
Section on Cardiology
Frederick E. Reed, MD
Section on Orthopaedics
CONSULTANTS
Oded Bar-Or, MD
Canadian Paediatric Society
William L. Risser, MD, PhD
| |
FOOTNOTES |
|---|
This subject review has been approved by the Council on Child and Adolescent Health.
The recommendations in this statement do not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.
| |
REFERENCES |
|---|
|
Top
Abstract
Background
Conclusion
References
|
|---|
frequency and attitudes.
J Intern Med.
1990;
227:407-411 [Medline]
This article has been cited by other articles:
 |
|
 |
|
  Council on Sports Medicine and Fitness Strength Training by Children and Adolescents Pediatrics, April 1, 2008; 121(4): 835 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Phillis, M. Y. Abeywardena, M. J. Adams, J. A. Kennedy, and R. J. Irvine Nandrolone Potentiates Arrhythmogenic Effects of Cardiac Ischemia in the Rat Toxicol. Sci., October 1, 2007; 99(2): 605 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. vandenBerg, D. Neumark-Sztainer, G. Cafri, and M. Wall Steroid Use Among Adolescents: Longitudinal Findings From Project EAT Pediatrics, March 1, 2007; 119(3): 476 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Ayotte Significance of 19-norandrosterone in athletes' urine samples Br. J. Sports Med., July 1, 2006; 40(suppl_1): i25 - i29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Calfee and P. Fadale Popular Ergogenic Drugs and Supplements in Young Athletes Pediatrics, March 1, 2006; 117(3): e577 - e589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rosenfield The Use of Ergogenic Agents in High School Athletes The Journal of School Nursing, December 1, 2005; 21(6): 333 - 339. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Y. McGINNIS Anabolic Androgenic Steroids and Aggression: Studies Using Animal Models Ann. N.Y. Acad. Sci., December 1, 2004; 1036(1): 399 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nilsson, P. Allebeck, B. Marklund, A. Baigi, and B. Fridlund Evaluation of a health promotion programme to prevent the misuse of androgenic anabolic steroids among Swedish adolescents Health Promot. Int., March 1, 2004; 19(1): 61 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Koch Performance-enhancing: Substances and Their Use Among Adolescent Athletes Pediatr. Rev., September 1, 2002; 23(9): 310 - 317. [Full Text] [PDF]
|
|
|
|
|
|
Committee on Sports Medicine and Fitness Strength Training by Children and Adolescents Pediatrics, June 1, 2001; 107(6): 1470 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Silver Use of Ergogenic Aids by Athletes J. Am. Acad. Ortho. Surg., January 1, 2001; 9(1): 61 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Faigenbaum, L. D. Zaichkowsky, D. E. Gardner, and L. J. Micheli Anabolic Steroid Use by Male and Female Middle School Students Pediatrics, May 1, 1998; 101 (5): e6 - e6. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | E-MAIL ALERTS | SEARCH |
